NLRP3 and psoriasis: Accumulating evidence demonstrates the role of NLRP3 in psoriasis patients, with potential reductions in disease activity and fatigue from mediating pro-inflammatory cytokines (e.g., IL-1β and TNF-alpha) regulated by the NLRP3 inflammasome.